All meetings are proceeding as scheuled and participants must be vaccinated and arrive with a recent negative COVID test to attend. Learn More

Aneuploidy in Cancer Development, Prognosis and Treatment

April 21–24, 2022

Original Dates: April 15–18, 2021

Chaired By

 Uri Ben-David, PhD, Tel Aviv University
 Elsa Logarinho, PhD, University of Porto
 Stefano Santaguida, PhD, University of Milan and European Institute of Oncology

Important Dates

 03/21/2022 -  Travel Form Due
 03/21/2022 -  Abstracts Due

Travel Agent Information

 Meeting #: Refer to your meeting email
 Hours: 8:00am – 8:00 pm EST M-F
 Domestic: 669-210-8002
 International : 623-516-6140

Venue Information

Castello Dal Pozzo
Via Visconti 8
28040 Oleggio Castello, Italy

About the Forbeck Foundation

 Forbeck Forum Information
 Travel Information
 General Program
 Frequently Asked Questions
 How to donate to WGFRF

Program Description

We propose a meeting, entitled “Aneuploidy in cancer development, prognosis and treatment”, that will bring together researchers from the cancer aneuploidy community. In particular, we envision a platform of creative thinking and scientific cooperation, gathering scientists with expertise and interests in studying how chromosome imbalances arise during tumorigenesis and how they can be targeted for cancer therapy.

During the meeting, participants will have the opportunity to discuss one of the most complex questions in cancer biology, namely whether and how aneuploidy contributes to tumorigenesis, and how this hallmark of cancer can be targeted therapeutically. This question is extremely timely and is currently addressed by several labs that are exploiting the powerful advances in genetics, cell biology and cancer biology to deconstruct the genetic makeup of cancer cells.

Focused discussions, prompted by talks from both junior and senior researchers, will invigorate research on these important problems. The well-established format of the Forbeck meetings will guarantee interactions among scientists using complementary approaches that will fuel collaborative and innovative thinking. Finally, this will also encourage the sharing of valuable resources and reagents across labs. We strongly believe that this meeting will empower researchers with new ideas and scientific allies long after the meeting has adjourned.

Notably, this meeting will follow the 2016 Annual Forbeck Forum on Chromosomal Instability and Aneuploidy. However, on top of the exciting developments that the field has seen in the past few years, the focus of the proposed meeting will be different from that of the 2016 meeting, and will emphasize the role of aneuploidy in tumor development, prognosis and treatment.

Travel Information

Travel forms are due 30 days prior to the start of the meeting to allow enough time to plan transportation.

The Malpensa Airport (MXP) is the preferred airport as it is only 25 minutes from the meeting location.

The Foundation will be providing airport transfer from MXP airport.

Submit Travel Form


Abstracts are due 30 days prior to the start of the meeting to allow enough time to prepare the meeting book.

Abstracts should be only one or two paragraphs outlining the theme of your presentation and should reflect the objective and spirit of the meeting (see above). Abstracts will be circulated about one week before the meeting. The meeting organizer will start requesting them a month before the meeting.

Submit Abstract

Forum Participants

Participant Institution
Samuel Bakhoum, MD, PhD Memorial Sloan Kettering Cancer Center
Ivana Barbaric, PhD The University of Sheffield
Uri Ben-David, PhD Tel Aviv University
Don Cleveland, PhD Ludwig Institute for Cancer Research/UCSD
Floris Foijer, PhD ERIBA - University Medical Center Groningen
Eva Gonzalez Suarez, PhD CNIO (Centro Nacional de Investigaciones Oncológicas)
Shai Izraeli, MD Schneider Children's Medical Center and Tel Aviv University
Elsa Logarinho, PhD Instituto de Biologia Molecular e Celular - Universidade do Porto
Sarah McClelland, PhD, BSc Barts Centre - Cancer Research UK
Rene Medema, PhD, PhD Netherlands Cancer Institute
Cristina Montagna, PhD Albert Einstein College of Medicine
Stefano Santaguida, PhD University of Milan and European Institute of Oncology
Rocio Sotillo Roman, PhD German Cancer Research Center (DKFZ)
Stephen Taylor, PhD University of Manchester
Eduardo Torres, PhD UMASS Medical School

Forum Scholars

Scholar Institution
Elsa Bernard, PhD Memorial Sloan Kettering Cancer Center
Pippa Cosper, MD, PhD University of Wisconsin, Madison
Elena Kuzmin, PhD McGill University
Thomas Watkins, PhD University College London and the Francis Crick Institute

For more than 35 years, the Forbeck Foundation has proven to be an excellent steward of donor funds and has remained focused on executing its mission. Interested in sponsoring this Forum? Contact us today for more information!